MetaADEDB 2.0 @ LMMD
Tetracycline
(YCIHPQHVWDULOY-FMZCEJRJSA-N)
Structure
SMILES
CN([C@@H]1C(=O)C(=C([C@@]2([C@H]1C[C@H]1C(=C(O)c3c([C@@]1(C)O)cccc3O)C2=O)O)O)C(=O)N)C.Cl
Molecular Formula:
C22H25ClN2O8
Molecular Weight:
480.895
Log P:
1.1313
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
7
TPSA:
181.62
CAS Number(s):
64-75-5
Synonym(s)
1.
Tetracycline
2.
4-Epitetracycline
3.
Achromycin
4.
Achromycin V
5.
Hostacyclin
6.
Sustamycin
7.
Tetrabid
8.
Tetracycline Hydrochloride
9.
Tetracycline Monohydrochloride
10.
Topicycline
11.
4 Epitetracycline
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1UrticariaFAERS: 31US FAERS
2NauseaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
3HypersensitivityFAERS: 18US FAERS
4VomitingFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
5Tooth LossFAERS: 14US FAERS
6Maternal exposure during pregnancyFAERS: 13US FAERS
7PainFAERS: 10US FAERS
8Abdominal discomfortFAERS: 9US FAERS
9PruritusFAERS: 7US FAERS
10SwellingFAERS: 7US FAERS
11Dental cariesFAERS: 6US FAERS
12HeadacheFAERS: 6US FAERS
13ToothacheFAERS: 6US FAERS
14Abdominal PainFAERS: 5US FAERS
15DeafnessFAERS: 5US FAERS
16Drug administered to patient of inappropriate ageFAERS: 5US FAERS
17Feeling abnormalFAERS: 5US FAERS
18DizzinessFAERS: 4US FAERS
19Emotional distressFAERS: 4US FAERS
20Enamel anomalyFAERS: 4US FAERS
21Teeth brittleFAERS: 4US FAERS
22Maternal exposure timing unspecifiedFAERS: 3US FAERS
23Mood swingsFAERS: 3US FAERS
24OverdoseFAERS: 3US FAERS
25Personality ChangeFAERS: 3US FAERS
26Stevens-Johnson SyndromeFAERS: 3US FAERS
27Tooth ErosionFAERS: 3US FAERS
28Amaurosis FugaxFAERS: 2US FAERS
29Bipolar I disorderFAERS: 2US FAERS
30Blood glucose decreasedFAERS: 2US FAERS
31BruxismFAERS: 2US FAERS
32Drug ineffectiveFAERS: 2US FAERS
33FatigueFAERS: 2US FAERS
34LymphadenopathyFAERS: 2US FAERS
35No adverse eventFAERS: 2US FAERS
36PancreatitisFAERS: 2US FAERS
37Product label issueFAERS: 2US FAERS
38Product use in unapproved indicationFAERS: 2US FAERS
39Respiratory arrestFAERS: 2US FAERS
40Tooth InfectionFAERS: 2US FAERS
41Visual ImpairmentFAERS: 2US FAERS
42Anaphylactic shockFAERS: 1US FAERS
43AngioedemaFAERS: 1US FAERS
44Aphthous StomatitisFAERS: 1US FAERS
45ArthritisFAERS: 1US FAERS
46AstheniaFAERS: 1US FAERS
47Back disorderFAERS: 1US FAERS
48BlindnessFAERS: 1US FAERS
49Cardiac ArrestFAERS: 1US FAERS
50Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
51Culture positiveFAERS: 1US FAERS
52DehydrationFAERS: 1US FAERS
53DiscomfortFAERS: 1US FAERS
54DiverticulitisFAERS: 1US FAERS
55Drug exposure during pregnancyFAERS: 1US FAERS
56Drug label confusionFAERS: 1US FAERS
57Drug resistanceFAERS: 1US FAERS
58EpilepsyFAERS: 1US FAERS
59Erythema MultiformeFAERS: 1US FAERS
60ErythemaFAERS: 1US FAERS
61Euphoric moodFAERS: 1US FAERS
62FibromyalgiaFAERS: 1US FAERS
63GlossitisFAERS: 1US FAERS
64HungerFAERS: 1US FAERS
65Impaired quality of lifeFAERS: 1US FAERS
66Incorrect drug administration durationFAERS: 1US FAERS
67Lactose IntoleranceFAERS: 1US FAERS
68LeukocytosisFAERS: 1US FAERS
69Loose toothFAERS: 1US FAERS
70MalaiseFAERS: 1US FAERS
71Mastication disorderFAERS: 1US FAERS
72Metabolic acidosisFAERS: 1US FAERS
73Middle insomniaFAERS: 1US FAERS
74Mouth swellingFAERS: 1US FAERS
75Multi-organ disorderFAERS: 1US FAERS
76Musculoskeletal PainFAERS: 1US FAERS
77MyocarditisFAERS: 1US FAERS
78Neck PainFAERS: 1US FAERS
79Neonatal disorderFAERS: 1US FAERS
80Neuronal neuropathyFAERS: 1US FAERS
81Night sweatsFAERS: 1US FAERS
82NystagmusFAERS: 1US FAERS
83Optic NeuropathyFAERS: 1US FAERS
84Oral painFAERS: 1US FAERS
85Oropharyngeal blisteringFAERS: 1US FAERS
86Physical product label issueFAERS: 1US FAERS
87Product use issueFAERS: 1US FAERS
88Quality of life decreasedFAERS: 1US FAERS
89RhabdomyolysisFAERS: 1US FAERS
90Skin lesionFAERS: 1US FAERS
91Skin reactionFAERS: 1US FAERS
92StillbirthFAERS: 1US FAERS
93Thirst decreasedFAERS: 1US FAERS
94ThirstFAERS: 1US FAERS
95TinnitusFAERS: 1US FAERS
96TremorFAERS: 1US FAERS
97Unresponsive to stimuliFAERS: 1US FAERS
98Vulvovaginal burning sensationFAERS: 1US FAERS
99Vulvovaginal pruritusFAERS: 1US FAERS
100WheezingFAERS: 1US FAERS
101nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.